Digital Health that Scales - Why a platform approach could be the path to performance
How can pharma learn from the successes and failures of past digital health initiatives, and bring impactful solutions to fruition reliably and repeatedly?
It’s clear that a fresh approach is needed; one that enables new solutions to be built on the success of others and facilitates scaling across regions and business units.
Adopting a platform approach provides a proven infrastructure and a flexible foundation on which to build a more stable digital health strategy, one that can be improved without starting afresh with each new initiative.
In this whitepaper, experts from S3 Connected Health, AstraZeneca, Janssen, Novartis, Roche, BMS, and Nen Health discuss the use of platforms in digital health and share their insights on:
- Why pharma companies should use a platform when developing a solution and the benefits of taking this approach
- The different types of digital health platforms
- The criteria used to assess which digital health platform is right for you
